Clarity appoints Dr Gillies O’Bryan-Tear to Chair Newly Formed Global Clinical Development Group
Sydney, Australia 31 March 2020 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O’Bryan-Tear will be chairing Clarity’s newly formed Global Clinical Development group. Dr O’Bryan-Tear joined the pharmaceutical industry in 1986 where he has spent 30 years in clinical development, medical management and…